1. Mechanisms of quinolone resistance

   • B. Wiedemann
   • P. Heisig

   OriginalPaper Pages: S73 - S79

2. Susceptibility of clinical bacterial isolates to ciprofloxacin in the united states

   • C. Thornsberry

   OriginalPaper Pages: S80 - S89

3. Prevalence of fluoroquinolone resistance in Europe

   • M. Kresken
   • D. Hafner
   • the Study Group ‘Bacterial Resistance’ of the Paul-Ehrlich-Society for Chemotherapy e. V.

   OriginalPaper Pages: S90 - S98

4. Prevalence of ciprofloxacin resistance in multiresistant gram-negative intensive care unit isolates

   • Chandra M. Khurana
   • Bette R. Wojack

   OriginalPaper Pages: S99 - S104

5. In vitro stepwise selection of resistance to quinolones, β-lactams and amikacin in nosocomial gram-negative bacilli

   • M. Michéa-Hamzehpour
   • Anneliese Kahr
   • J. -C. Pechère

   OriginalPaper Pages: S105 - S110

6. Quinolone resistance inPseudomonas aeruginosa andStaphylococcus aureus. Development during therapy and clinical significance

   • A. Dalhoff

   OriginalPaper Pages: S111 - S121

7. Clinical significance and spread of fluoroquinolone resistant uropathogens in hospitalised urological patients

   • K. G. Naber
   • F. Wagenlehner
   • P. Heisig

   OriginalPaper Pages: S122 - S127

8. Analysis of nosocomial outbreaks with multiply and methicillin-resistantStaphylococcus aureus (MRSA) in Germany: Implications for hospital hygiene

   • W. Witte
   • Christine Braulke
   • Christa Cuny

   OriginalPaper Pages: S128 - S134

9. Control of an outbreak of methicillin-resistantStaphylococcus aureus (MRSA) by hygienic measures in a general intensive care unit

   • W. Lingnau
   • F. Allerberger

   OriginalPaper Pages: S135 - S139

10. Bacterial resistance to fluoroquinolones: Lessons to be learned

    • P. Ball

    OriginalPaper Pages: S140 - S147